A cohort study found that pre-radical prostatectomy levels greater than 20 ng/mL were associated with increased all-cause mortality risk and prostate cancer-specific mortality risk. Patients with a ...
Men with high-risk prostate cancer have a higher likelihood of residual disease after prostatectomy and may require radiation ...
Among men who had persistent prostate-specific antigen (PSA) after radical prostatectomy (RP), a higher preoperative PSA ...
A meta-analysis involving more than 6000 men suggested that adding hormone therapy (HT) to radiation after radical prostatectomy improves overall survival (OS) in those with higher pre-radiation ...
After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels. Persistently elevated PSA levels indicate residual cancer and are linked to ...
At 8 years, SBRT and radical prostatectomy had similar disease control in the PACE-A trial, with less urinary incontinence ...
Prostate cancer has a well-earned reputation for being one of the more trackable malignancies in medicine. Since the mid-1980s, a single blood test measuring prostate-specific antigen, or PSA, has ...
Among men with PSA persistence after radical prostatectomy, a higher preoperative PSA surprisingly was linked to lower mortality. Men with PSA persistence and preoperative PSA >20 ng/mL had 31% lower ...